InvestorsHub Logo
Followers 17
Posts 882
Boards Moderated 0
Alias Born 04/30/2014

Re: Evaluate post# 94078

Monday, 01/09/2017 1:51:54 PM

Monday, January 09, 2017 1:51:54 PM

Post# of 699722
I truly hope you are correct, but the variables in this trial are already highly complex and numerous, to add follow-on treatments and unexpected deaths to the mix does not help with the statistics.

Most here know that I am long (to the extreme), underwater (to the extreme), and invested in a number of ways, with January options and December warrants to the extreme.

However, I am a scientist and I try to be realistic, so I understand that this trial is confounded and I understand what that means scientifically.

As I have mentioned on a number of occasions and Flipper has highlighted today, there will need to be a confirmatory trial, even if it is a short one. I expect once the results are unblinded that DCVax-L will still be made available on a compassionate use basis while the confirmatory trial is conducted. This only makes sense.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News